Company intelligence
BeOne Medicines
Cancer has no borders. Neither do we.
About BeOne Medicines
BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has a growing global team spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before. To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram. We all share the responsibility to report adverse events observed with our products so that they may be investigated, actioned, and communicated accordingly. To report an adverse event or side effect, please talk to your healthcare provider and contact us here: https://beonemedicines.com/contact-us/report-adverse-event/.
Verified activity
Signals from BeOne Medicines
9 published signals
People
BeOne Medicines is hiring an Associate Director, Collaborative Operations for Health Engagement, Representation, and Enrollment (COHERE) to drive patient enrollment strategies, community engagement, and site partnerships across clinical research programs.
Reported by Isabella Fajardo
People
BeOne Medicines hired Patricia Lindler as Associate Director, Drug Substance Manufacturing - Cell Culture Operations.
Reported by Patricia Lindler
People
BeOne Medicines is hiring a senior engineer for the Automation space at the Hopewell facility.
Reported by Matt Casey
Presence & Recognition
BeOne Medicines held a remote Leadership Team Meeting in Munich.
Reported by Astrid Overbeck
People
BeOne Medicines secured key positions in August, demonstrating strong team performance.
Reported by Astrid Overbeck
People
BeOne Medicines appointed Astrid Overbeck as HR Business Partnerin for the German office, retaining her full-time engagement from part-time.
Reported by Astrid Overbeck
Presence & Recognition
BeOne Medicines is participating in Blood Cancer Awareness Month with a focus on advancing innovation, supporting informed care decisions, and helping more patients benefit from scientific progress.
Reported by BeOne Medicines
Presence & Recognition
BeOne Medicines kicked off Global Development Week for Europe and Mena colleagues live from the Basel Office, streaming online to all countries and regions covered.
Reported by Bruno Casimiro
Research & Knowledge
BeOne Medicines announced positive results from a further analysis of its Phase 3 study evaluating a combination regimen including a HER2-targeted bispecific antibody licensed in Asia Pacific (excluding Japan) and chemotherapy with and without its PD-1 inhibitor in patients with HER2+ GEA.
Reported by BeOne Medicines